CClinicalTrials.gg
RecruitingNCT06965699ProSauceUpdated Sep 23, 2025

The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults

An interventional study of ProSauce and low-protein sauce in Malnutrition Elderly and Protein Malnutrition, sponsored by University of Exeter. Recruiting at 1 site in United Kingdom. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-23.

Sponsored by University of Exeter · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Oct 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Jul 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to determine whether meals fortified with plant-based high protein sauce (ProSauce) provide better metabolic availability of essential amino acids compared to meals with standard lower-protein sauce without resulting in excessive gut fullness and satiety. The main questions it aims to answer are:

Does meals with high-protein sauce deliver better metabolic availability of amino acid profile? Does this high-protein sauce also not lead to excessive appetite suppression due to its liquid form? Researchers will compare high protein sauce to a commercially available standard low protein sauce.

Participants will consume two meals, either protein-fortified or standard low-protein sauce, in a randomised order with at least a one-week washout period between each meal. The investigators will collect venous blood samples over a 6-hour postprandial period to measure plasma essential (and non-essential) amino acid and insulin concentrations. The investigators will also measure appetite-related hormones from venous plasma and assess subjective appetite using a visual analogue scale, taken in parallel with the blood sample time points.

02

Conditions studied

  • Malnutrition Elderly
  • Protein Malnutrition

Browse trials for

Keywords

  • plant-based protein sauce
  • older adults
  • amino acid metabolic availability
  • appetite regulation
03

In context

Kwashiorkor

44 studies on the registry are indexed under Kwashiorkor; 6 are open to participants now.

This study's planned enrollment of 20 is below the median of 93 across 32 interventional studies indexed under Kwashiorkor.

Browse Kwashiorkor studies →

Lead sponsor

University of Exeter is the lead sponsor of 138 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 60 and over
  • Living independently in the community
  • Capacity to provide informed consent
  • Non-smoking (vaping is considered smoking)
  • No known medical conditions that might influence the study outcomes, e.g., heart disease, diabetes mellitus, obesity, disthyroidism and other endocrinopathies and renal failure
  • Not taking any medications that might influence the study outcomes e.g., taking anabolic steroids or corticosteroids long term
  • No clinically diagnosed eating disorders
  • No severe dislike or allergy to any of the study food
  • No hospitalisations in the last 6 months
  • Not dieting and weight stable for 3 months before the study (\< 3 kg change in weight)

Exclusion criteria

Exclusion Criteria:

  • Age \< 60y
  • Smoking
  • Food allergies
  • Cognitive and mobility issues
  • Hospitalisation in the last 6 months
  • Known medical conditions that might influence the study outcomes
  • Taking medications that influence the study outcomes
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    ProSauce

    Dietary Supplement: ProSauce

  • Placebo comparator
    standard sauce

    Dietary Supplement: low-protein sauce

Interventions

  • Dietary supplementProSauce

    10g additional protein from ProSauce

  • Dietary supplementlow-protein sauce

    Commercially available standard low-protein sauce

06

What researchers measure

Primary outcomes

  1. Concentrations of essential amino acids

    Baseline and postprandial plasma amino acid concentrations will be measured to provides valuable insights into protein digestion and absorption.

    Time frame: Essential amino acid concentrations at time points of baseline, immediately after breakfast (t =0 minute) and t = 20, 40, 60, 90, 120, 180, 240, 300, 360 minutes.

Secondary outcomes

  1. Concentrations of appetite-related gut hormones

    Plasma appetite-related hormones i.e., acylated ghrelin, PYY, GLP-1, CCK, will be measured at certain time points via cannulation.

    Time frame: Appetite-related gut hormones will be measured at time points of baseline, immediately after breakfast (t =0 minute) and t = 20, 40, 60, 90, 120, 150, 180, 210, 240 minutes.

07

Study locations

1 of 1 sites recruiting
  • University of Exeter
    Exeter, Devon EX44DZ, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06965699
Lead sponsor
University of Exeter
Responsible party
Sponsor
First posted
May 11, 2025
Start date
Jul 10, 2025
Primary completion
Oct 30, 2025 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Sep 23, 2025

Study contacts

Zhuoxiu Jin, Dr
Contact
z.jin3@exeter.ac.uk
+447529283410
Joanna Bowtell, Prof
Contact
Joanna Bowtell, Prof
principal investigator · University of Exeter

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion